At the HEP Special Meeting, the HEP Unitholders will be asked to consider and vote on proposals to (i) approve the Merger Agreement and the transactions contemplated thereby (the “Merger Proposal”) and (ii) approve the adjournment of the HEP Special Meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies in the event there are not sufficient votes at the time of the HEP Special Meeting to approve the Merger Proposal. Pursuant to the Merger Agreement, HF Sinclair has agreed that it will vote, or cause to be voted, all HEP Common Units then owned beneficially or of record by HF Sinclair or any of its subsidiaries in favor of the Merger Proposal. HF Sinclair currently holds approximately 47% of the issued and outstanding HEP Common Units through its subsidiaries, along with the non-economic general partner interest and the Special General Partner Interest.
On October 16, 2023, HF Sinclair filed with the SEC an amended registration statement on Form S-4, which included a notice of meeting and a joint proxy statement/prospectus of HF Sinclair and HEP with respect to (i) the HF Sinclair Stock Issuance Proposal, (ii) the HF Sinclair Special Meeting, (iii) the Merger Proposal and (iv) the HEP Special Meeting. The registration statement on Form S-4 became effective under the Securities Act of 1933, as amended (the “Securities Act”), on October 24, 2023. On October 26, 2023, and in connection with the Merger Agreement and the transactions contemplated thereby, including the HF Sinclair Stock Issuance, the HF Sinclair Special Meeting, the Merger and the HEP Special Meeting, (i) HF Sinclair filed with the SEC a prospectus pursuant to Rule 424(b)(3) promulgated under the Securities Act (the “HF Sinclair Prospectus”), and (ii) HEP filed with the SEC a definitive proxy statement on Form DEFM14A pursuant to Section 14(a) of the Exchange Act (the “HEP Proxy Statement”). Each of the HF Sinclair Prospectus and the HEP Proxy Statement included a notice of meeting and a proxy statement/prospectus (the “Joint Proxy Statement/Prospectus”). HF Sinclair and HEP first mailed the Joint Proxy Statement/Prospectus to HF Sinclair Stockholders and HEP Unitholders on or about October 26, 2023. A copy of the Joint Proxy Statement/Prospectus is attached hereto as Exhibit (a)(1). A copy of the Merger Agreement is attached as Annex A to the Joint Proxy Statement/Prospectus. All references in this Amended Transaction Statement to Items numbered 1001 to 1016 are references to Items contained in Regulation M-A under the Exchange Act.
This Amended Transaction Statement is being filed with the SEC to (i) amend Item 16 of the Schedule 13E-3 to add as exhibit (a)(16) the Current Report on Form 8-K of HF Sinclair, filed with the SEC on October 30, 2023 and incorporated herein by reference and to add as exhibit (a)(17) the Current Report on Form 8-K of HEP, filed with the SEC on October 30, 2023 and incorporated herein by reference (collectively, the “October 30 Form 8-Ks”), to add as exhibit (a)(18) the Current Report on Form 8-K of HF Sinclair, filed with the SEC on November 14, 2023 and incorporated herein by reference and to add as exhibit (a)(19) the Current Report on Form 8-K of HEP, filed with the SEC on November 14, 2023 and incorporated herein by reference, (ii) provide supplemental disclosure set forth herein, (iii) provide disclosure regarding amendments to HEP’s Credit Agreement (as defined below), (iv) provide disclosure regarding the Exchange Offers and Consent Solicitations (as defined below) and (v) provide disclosure regarding the HEP Indentures (as defined below).
Supplemental Disclosure
The October 30 Form 8-Ks disclose the following HEP awards held by directors and executive officers as of October 26, 2023:
HEP Awards Held by Directors and Executive Officers
The unvested Partnership LTIP Service Awards, Director LTIP Awards, Partnership Performance LTIP Awards and Partnership Cash Awards outstanding and held by each of the General Partner’s executive officers and directors as of October 26, 2023 is set forth in the table below.
| | | | | | | | | | | | | | | | |
Name (1) | | Partnership Service LTIP Award (#) | | | 2020 Partnership Performance LTIP Award (#) (2) | | | 2021, 2022 or 2023 Partnership Performance LTIP Award (#) (2) | | | Value of Partnership Cash Award to he Converted to Parent Cash Award ($) | |
Executive Officers | | | | | | | | | | | | | | | | |
Michael C. Jennings(3) | | | — | | | | — | | | | — | | | | — | |
John Harrison | | | — | | | | — | | | | — | | | | — | |
Robert I. Jamieson | | | 28,147 | | | | 10,488 | | | | 11,412 | | | $ | 181,123 | |
Vaishali S. Bhatia | | | — | | | | — | | | | — | | | | — | |
Non-Employee Directors | | | | | | | | | | | | | | | | |
Larry R. Baldwin | | | 11,627 | | | | — | | | | — | | | | — | |
Christine B. LaFollette | | | 11,627 | | | | — | | | | — | | | | — | |
James H. Lee | | | 11,627 | | | | — | | | | — | | | | — | |
Eric L. Mattson | | | 11,627 | | | | — | | | | — | | | | — | |
Mark A. Petersen | | | 11,627 | | | | — | | | | — | | | | — | |
(1) | Additional individuals may have been identified as “executive officers” or “Named Executive Officers” in the most recent HEP Annual Report on Form 10-K, but the following individuals are no longer providing services to HEP as of the date of this joint proxy statement and therefore will receive no compensation in connection with the Merger: Mr. Mark T. Cunningham (former Senior Vice President, Operations and Engineering) and Mr. Richard L. Voliva (former President). |
(2) | All Partnership Performance LTIP Awards are reflected at target values. With respect to the 2020 Partnership Performance LTIP Awards, the awards will be settled using actual performance achievement at the end of the performance period, which may be higher or lower than the target values shown here. |
(3) | Mr. Jennings is also the Chairperson of the GP Board. |
HEP Credit Agreement
As of June 30, 2023, HEP had outstanding borrowings of $606 million under its senior secured revolving credit facility pursuant to that certain Third Amended and Restated Credit Agreement dated as of July 27, 2017 by and among HEP, as borrower, Wells Fargo Bank, National Association, in its capacity as administrative agent, and the lenders party thereto (as amended, restated, supplemented or otherwise modified from time to time, the “Credit Agreement”). In connection with the consummation of the Merger, HEP expects to amend the Credit Agreement to, among other things, (a) provide a guaranty from HF Sinclair and terminate all guaranties from subsidiaries of HEP, (b) amend the definition of “Investment Grade Rating” in the Credit Agreement to reference the credit rating of HF Sinclair’s senior unsecured indebtedness, (c) eliminate the requirement to deliver separate audited and unaudited financial statements for HEP and its subsidiaries and only provide certain segment-level reporting for HEP with any compliance certificate delivered in accordance with the Credit Agreement and (d) amend certain covenants to eliminate certain restrictions on (i) amendments to intercompany contracts, (ii) transactions with HF Sinclair and its subsidiaries and (iii) investments in and contributions, dividends, transfers and distributions to HF Sinclair and its subsidiaries. There can be no assurance that the administrative agent and the lenders party thereto will agree to amend the Credit Agreement in a timely manner, or on acceptable terms, if at all.
Exchange Offers and Consent Solicitations
As of June 30, 2023, HEP had outstanding $400 million aggregate principal amount of 6.375% senior notes due 2027 (the “6.375% Senior Notes”) and $500 million aggregate principal amount of 5.000% senior notes due 2028 (the “5.000% Senior Notes” and, together with the 6.375% Senior Notes, the “Senior Notes”). On October 30, 2023, HF Sinclair and HEP announced the commencement of private offers by HF Sinclair to all Eligible Holders (as defined in the Exchange Offer Memorandum) to exchange (the “Exchange Offers”) any and all outstanding 6.375% Senior Notes and 5.000% Senior Notes, for new notes to be issued by HF Sinclair, with registration rights, and cash, pursuant to the terms and subject to the conditions set forth in a confidential exchange offer memorandum and consent solicitation statement, dated October 30, 2023 (the “Exchange Offer Memorandum”). Concurrently with the Exchange Offers, HF Sinclair is soliciting consents (the “Consent Solicitations”) to adopt certain proposed amendments to the indentures governing the existing Senior Notes to, among other things, eliminate from each HEP indenture, as it relates to each series of Senior Notes (i) substantially all of the restrictive covenants, (ii) certain of the events which may lead to an “Event of Default”, (iii) the SEC reporting covenant and (iv) the requirement of HEP to offer to purchase the Senior Notes upon a change of control (collectively, the “Proposed Amendments”). The Exchange Offers and the Consent Solicitations will expire at 5:00 p.m., New York City time, on November 29, 2023, unless extended or earlier terminated (such date and time, as they may be extended or terminated, the “Expiration Date”). The Exchange Offers and Consent Solicitations are subject to the consummation of the Merger. The Exchange Offers and Consent Solicitations are being made only pursuant to the terms and subject to conditions set forth in the Exchange Offer Memorandum.
On November 13, 2023, HF Sinclair announced that as of 5:00 p.m., New York City time, on November 13, 2023, (i) $394,226,000 in aggregate principal amount of the 6.375% Senior Notes, representing approximately 98.56% of the total outstanding principal amount of the 6.375% Senior Notes, and (ii) $486,003,000 in aggregate principal amount of the 5.000% Senior Notes, representing approximately 97.20% of the total outstanding principal amount of the 5.000% Senior Notes, have been validly tendered and not validly withdrawn (and consents thereby validly given and not validly withdrawn) in connection with the Exchange Offers and Consent Solicitations.
HF Sinclair and HEP also announced that the previous deadline for holders to tender their Senior Notes and be eligible to receive $1,000 principal amount of such series of new notes to be issued by HF Sinclair (the “New Notes”), which includes the early participation premium, payable in principal amount of New Notes, of $50, plus a payment of $1.00 in cash has been extended to the Expiration Date. Currently, this is the same time and date as the Expiration Date for the Exchange Offers and Consent Solicitations. As a result, the consideration to be paid for Senior Notes validly tendered (i) at or prior to the Early Participation Date (as defined in the Exchange Offer Memorandum) and (ii) following the Early Participation Date, but at or prior to the Expiration Date, will be the same.
The Exchange Offer Memorandum and other documents relating to the Exchange Offers and Consent Solicitations will be distributed only to Eligible Holders (as defined in the Exchange Offer Memorandum) of Senior Notes. The Exchange Offers and Consent Solicitations are not being made to holders of Senior Notes in any jurisdiction in which the making or acceptance thereof would not be in compliance with the securities, blue sky or other laws of such jurisdiction. The new notes to be issued by HF Sinclair have not been approved or disapproved by any regulatory authority, nor has any such authority passed upon the accuracy or adequacy of the Exchange Offer Memorandum. The complete terms and conditions of the Exchange Offers and Consent Solicitations are described in the Exchange Offer Memorandum.
HEP Indentures
As of 11:00 a.m., New York City time, on November 10, 2023, HF Sinclair, on behalf of the HEP Issuers (as defined below), had received valid consents from at least a majority of the outstanding aggregate principal amount of each series of the Senior Notes, which amounts were sufficient to constitute the requisite consents to approve the Proposed Amendments. On November 10, 2023, HEP and Holly Energy Finance Corp., a Delaware corporation (“Finance Corp.” and, together with HEP, the “HEP Issuers”), entered into (i) a Second Supplemental Indenture (the “2027 Notes Second Supplemental Indenture”) among the HEP Issuers, as issuers, the other subsidiary guarantors party thereto (the “Guarantors”) and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”), to that certain Indenture, dated as of April 8, 2022, among the HEP Issuers, as issuers, the Guarantors and the Trustee, as trustee (as supplemented, the “2027 Notes Indenture”), relating to the 6.375% Senior Notes and (ii) a Third Supplemental Indenture (the “2028 Notes Third Supplemental Indenture”) among the HEP Issuers, as issuers, the Guarantors and the Trustee, as trustee, to that certain Indenture, dated as of February 4, 2020, among the HEP Issuers, as issuers, the Guarantors and the Trustee, as trustee (as supplemented, the “2028 Notes Indenture” and, together with the 2027 Notes Indenture, the “HEP Indentures”), relating to the 5.000% Senior Notes.
Each of the 2027 Notes Second Supplemental Indenture and the 2028 Notes Third Supplemental Indenture was entered into to effectuate the Proposed Amendments to the 2027 Notes Indenture and the 2028 Notes Indenture, respectively, for which consents were solicited in the previously announced Exchange Offers and Consent Solicitations. Following execution of the 2027 Notes Second Supplemental Indenture and the 2028 Notes Third Supplemental Indenture, the consents received were not able to be revoked. Each of the 2027 Notes Second Supplemental Indenture and the 2028 Notes Third Supplemental Indenture was effective upon execution but will only become operative upon the settlement date of the applicable Exchange Offer, which is expected to be on or about the third business day following the Expiration Date (the “Settlement Date”). The Settlement Date is expected to be on or about December 4, 2023, unless HF Sinclair extends the Expiration Date or terminates the Exchange Offers.
Pursuant to General Instruction F to Schedule 13E-3, the information contained in the Joint Proxy Statement/Prospectus, including all annexes thereto, is expressly incorporated herein by reference in its entirety and responses to each item herein are qualified in their entirety by the information contained in the Joint Proxy Statement/Prospectus and the annexes thereto. The cross-references below are being supplied pursuant to General Instruction G to Schedule 13E-3 and show the location in the Joint Proxy Statement/Prospectus of the information required to be included in response to the items of Schedule 13E-3. Terms used but not defined in this Amended Transaction Statement have the meanings given to them in the Joint Proxy Statement/Prospectus.
All information concerning HEP contained in, or incorporated by reference into, this Amended Transaction Statement was supplied by HEP. Similarly, all information concerning any other filing person contained in, or incorporated by reference into, this Amended Transaction Statement was supplied by such filing person.
ITEM 1. | SUMMARY TERM SHEET |
Regulation M-A Item 1001
The information set forth in the Joint Proxy Statement/Prospectus under the following captions is incorporated herein by reference:
“Summary Term Sheet”
“Questions and Answers”
ITEM 2. | SUBJECT COMPANY INFORMATION |
Regulation M-A Item 1002
(a) | Name and Address. The information set forth in the Joint Proxy Statement/Prospectus under the following captions is incorporated herein by reference: |
“Summary Term Sheet—The Parties”
“The Parties”
(b) | Securities. The information set forth in the Joint Proxy Statement/Prospectus under the following captions is incorporated herein by reference: |
“Special Meeting of HEP Unitholders”
“Special Factors—Interests of Certain Persons in the Merger”
“Special Factors—Treatment of HEP Equity Awards”
“Comparative Market Prices and Cash Dividend/Distribution Information”
(c) | Trading Market and Price. The information set forth in the Joint Proxy Statement/Prospectus under the following caption is incorporated herein by reference: |
“Comparative Market Prices and Cash Dividend/Distribution Information”
3